Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II

INTRODUCTION: Dyslipidaemia is a major risk factor for coronary heart disease (CHD). There is a lack of data on the extent of lipid abnormalities and lipid-lowering therapy (LLT) in Singapore. METHODS: The Dyslipidemia International Study (DYSIS) II was a multinational observational study of patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Singapore Med J
Autors principals: Poh, Kian-Keong, Chin, Chee Tang, Tong, Khim Leng, Tan, Julian Ko Beng, Lim, Jee Seong, Yu, Weixuan, Horack, Martin, Vyas, Ami, Lautsch, Dominik, Ambegaonkar, Baishali, Brudi, Philippe, Gitt, Anselm K
Format: Artigo
Idioma:Inglês
Publicat: Singapore Medical Association 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7911083/
https://ncbi.nlm.nih.gov/pubmed/30773600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11622/smedj.2019021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars